Orexigen Therapeutics, Inc. (NASDAQ:OREX)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity.

Recs

0
Player Avatar tichster (< 20) Submitted: 2/2/2011 9:37:15 PM : Outperform Start Price: $2.72 OREX Score: +21.01

oversold

Featured Broker Partners


Advertisement